Catheter-based treatment of atherosclerosis

References

• Parisi AF, Folland ED, Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. N Engl J Med 1992; 326(1): 10–6
   PubMed Web of Science ®Google Scholar
• Invasive compared with non-invasive treatment in unstable coronary- artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet 1999; 354(9180): 708–15
   PubMed Web of Science ®Google Scholar
• A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO lib) Angioplasty Substudy Investigators. N Engl J Med 1997; 336(23): 1621–8 [Erratum, N Engl J Med 1997; 337(4): 287]
   PubMed Web of Science ®Google Scholar
• Vandormael M, Reifart N, Preusler W, et al. Six months follow-up results following excimer laser angioplasty, rotational atherectomy and balloon angioplasty for complex lesions: ERBAC study. (Abstr) Circulation 1994; 90(Suppl 1): 213A
   Google Scholar
• Morice M-C, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346(23): 1773–80
   PubMed Web of Science ®Google Scholar
• Mauri L, Bonan R, Weiner BH, et al. Cutting balloon angioplasty for the prevention of restenosis: results of the Cutting Balloon Global Randomized Trial. Am J Cardiol 2002; 90(10): 1079–83
   PubMed Web of Science ®Google Scholar
• Leon MB, Teirstein PS, Moses JW, et al. Localized intracoronary gammaradiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001; 344(4): 250–6
   PubMed Web of Science ®Google Scholar
• Popma JJ, Suntharalingam M, Lansky AJ, et al. Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis. Circulation 2002; 106(9): 1090–6
   PubMed Web of Science ®Google Scholar
• Baim DS, Wahr D, George B, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aortocoronary bypass grafts. Circulation 2002; 105(11): 1285–90
   PubMed Web of Science ®Google Scholar
• Stone GW, Rogers C, Hermiller J, et al. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aortocoronary bypass grafts. Circulation 2003; 108(5): 548–53
   Google Scholar
• Yadav JS. SAPPHIRE study: preliminary results. Available at: http://www.clevelandclinic.org/neuroscience/professionals/news/stroke/sapphire.htm. Accessed Dec 11, 2003
   Google Scholar
• Bech GJ, De Bruyne B, Pijls NH, et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation 2001; 103(24): 2928–34
   PubMed Web of Science ®Google Scholar
• Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med 1996; 335(4): 217–25 [Erratum, N Engl J Med 1997; 336(2): 147]
   PubMedGoogle Scholar
• Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001; 344(25): 1879–87
   PubMed Web of Science ®Google Scholar
• Bosch JL, Hunink MG. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology 1997; 204(1): 87–96 [Erratum, Radiology 1997; 205(2): 584]
   Google Scholar
• Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003; 349(8): 733–42
   PubMed Web of Science ®Google Scholar
• Giri S, Rosenfield K, Eisenhauer AC, et al. A study to evaluate the safety and effectiveness of renal stenting after failed angioplasty: acute and follow-up results of quantitative renal angiography in the ASPIRE-2 trial. Presented at the American Heart Association Scientific Sessions, Nov 2002, Chicago
   Google Scholar
• Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991; 325(7): 445–53
   PubMed Web of Science ®Google Scholar
• Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995; 273(18): 1421–8
   PubMed Web of Science ®Google Scholar
• Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998; 339(20): 1415–25
   PubMed Web of Science ®Google Scholar
• Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with Clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001; 358(9281): 527–33
   PubMed Web of Science ®Google Scholar
• Steinhubl SR, Berger PB, Mann JT III, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002; 288(19): 2411–20 [Erratum, JAMA 2003; 289(8): 987]
   PubMed Web of Science ®Google Scholar
• Lincoff AM, Bittl JA, Harrington RA, et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 2003; 289(7): 853–63 [Erratum, JAMA 2003; 289(13): 1638]
   PubMed Web of Science ®Google Scholar
• Serruys PW, de Feyter P, Macaya C, et al. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. JAMA 2002; 287(24): 3215–22
   PubMed Web of Science ®Google Scholar